福萊新材(605488.SH):擬4億元建設煙台富利新型新材料(二期)項目
格隆匯3月7日丨福萊新材(605488.SH)公佈,為進一步深化公司新型材料的產業佈局,提升整體經營效益,持續擴大在行業中的競爭優勢,實現戰略佈局和長遠規劃,公司控股子公司煙台富利計劃由其作為實施主體,在其山東省海陽市現有廠區內投資建設可年產46,000噸熱收縮膜新型新材料(二期)項目。項目總投資預計4億元人民幣,建設週期約1年7個月,本項目擬新建廠房及配套設施、新增2條熱收縮膜生產線。授權公司董事長及經營管理層辦理上述投資項目的全部手續,包括但不限於簽署相關合同、提交政府審批申請文件等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.